The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type

The Journal of Physiology
T M LewisN Millar

Abstract

1. A stable mammalian cell line (L-alpha 3 beta 4) has been established which expresses the cloned rat neuronal nicotinic acetylcholine receptor (nAChR) subunits alpha 3 and beta 4, which are the most abundant in autonomic ganglia. Ion channel properties of nAChRs expressed in L-alpha 3 beta 4 cells were investigated by single-channel and whole-cell recording techniques, and compared with both rat alpha 3 beta 4 nAChRs expressed in Xenopus oocytes, and endogenous nicotinic receptors in rat superior cervical ganglion (SCG) neurones, using identical solutions for all cell types. 2. Acetylcholine (ACh) caused activation of single ion channel currents with a range of amplitudes. Some channels had high conductances (30-40 pS), and relatively brief lifetimes; these resembled the predominant native channel from SCG. Other channels had low conductances (20-26 pS) and long bursts of openings which were quite unlike native channels, but which were similar to channels formed by alpha 3 beta 4 in oocytes. Both types often occurred in the same patch. 3. Cytisine was about 3 times more potent than ACh (low-concentration potency ratio) in L-alpha 3 beta 4 cells, which is not dissimilar to the 5-fold potency ratio found in both SCG and oocytes...Continue Reading

References

Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J BoulterJ Patrick
Aug 1, 1987·Molecular and Cellular Biology·C Chen, H Okayama
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R C Mulligan, P Berg
Jun 1, 1995·Trends in Neurosciences·W N Green, N S Millar
Jan 1, 1995·Annual Review of Physiology·D S McGehee, L W Role
Oct 1, 1996·Pflügers Archiv : European journal of physiology·L J Greenfield, R L Macdonald
May 1, 1997·Journal of Neurochemistry·S J LansdellN S Millar

❮ Previous
Next ❯

Citations

May 10, 2005·European Journal of Pharmacology·William MarszalecToshio Narahashi
Apr 20, 2000·European Journal of Pharmacology·S VailatiC Gotti
Jun 24, 2003·European Journal of Pharmacology·Eric CarbonnelleCecilia Gotti
May 24, 2003·Neuropharmacology·Britta HahnIan P Stolerman
Jul 16, 1999·Neurochemistry International·T NarahashiK Nagata
May 31, 2002·Autonomic Neuroscience : Basic & Clinical·Vladimir I Skok
Sep 21, 2002·Autonomic Neuroscience : Basic & Clinical·Andrei Yu Bobryshev, Vladimir I Skok
Feb 22, 2000·British Journal of Pharmacology·M Shah, D G Haylett
Mar 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·S FucileF Eusebi
Oct 1, 1998·Proceedings. Biological Sciences·M N RivoltaM C Holley
Feb 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Eleonora PalmaFabrizio Eusebi
Dec 3, 1999·The Journal of Physiology·V E WotringD S Weiss
Apr 14, 1999·The Journal of Physiology·M E Nelson, J Lindstrom
May 20, 1999·The Journal of Physiology·S FucileP Bregestovski
Jul 4, 2001·The Journal of Physiology·A A SelyankoD A Brown
Dec 27, 2015·Pflügers Archiv : European journal of physiology·Ivana A SouzaGerald W Zamponi
Sep 9, 2008·Trends in Neurosciences·Nelson P Barrera, J Michael Edwardson
Feb 5, 2008·Journal of Neuroscience Methods·Ron C HoggDaniel Bertrand
Feb 5, 2008·British Journal of Pharmacology·N S Millar
Jan 15, 2005·Progress in Neurobiology·C Gotti, F Clementi
Jun 2, 2009·Biochemical Pharmacology·Cecilia GottiMichele Zoli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.